RxDoctor Payments Data

Alexandra Lev

Adult Health · Hillsborough, NJNPI 1568817054

Payments from drug & device makers

$1,714in general payments, 2019–2025

Across 74 payments — averaging $23.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$668
  • E.r. Squibb & Sons, L.L.C.$334
  • Cvrx, Inc.$151
  • Abiomed$79
  • Novartis$62
  • Johnson & Johnson$49
  • plus $371 from 15 others

What the payments were for

  • Food & beverage$1,714100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,714 in reported general payments places this provider in the 80th percentile of 1,135 adult health providers in New Jersey.

See all adult health providers in New Jersey

Medicare billing

Part B allowed, 2024
$179,433
Medicare patients
363
Services billed
1,641

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban53$41,796
EntrestoSacubitril/Valsartan22$11,749
FarxigaDapagliflozin Propanediol29$9,494
JardianceEmpagliflozin11$4,848
Midodrine Hcl11$845
Losartan Potassium31$418
Amiodarone Hcl15$380
Metoprolol Succinate22$319
Metoprolol Tartrate31$274
Atorvastatin Calcium14$258
Hydralazine Hcl16$210
Amlodipine Besylate21$172
Furosemide35$119
Lisinopril11$118
Spironolactone11$70

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$42$41,79653 claims
NovartisEntresto$62$11,74922 claims
AstraZenecaFarxiga$40$9,49429 claims
Boehringer IngelheimJardiance$34$4,84811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,135 adult health providers in New Jersey.

Other adult health in Hillsborough

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →